BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19530994)

  • 1. Modulation of regulatory T cells in health and disease: role of toll-like receptors.
    Nyirenda MH; O'Brien K; Sanvito L; Constantinescu CS; Gran B
    Inflamm Allergy Drug Targets; 2009 Jun; 8(2):124-9. PubMed ID: 19530994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells and Toll-like receptors: what is the missing link?
    Dai J; Liu B; Li Z
    Int Immunopharmacol; 2009 May; 9(5):528-33. PubMed ID: 19539562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of immune responses through direct activation of Toll-like receptors to T cells.
    Liu G; Zhang L; Zhao Y
    Clin Exp Immunol; 2010 May; 160(2):168-75. PubMed ID: 20128825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on Toll-like receptors pathways regulating function of regulatory T cells].
    Guo P; Zhang H; Li C; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1701-1712. PubMed ID: 33164449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.
    Lien E; Zipris D
    Curr Mol Med; 2009 Feb; 9(1):52-68. PubMed ID: 19199942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying blockade of allograft acceptance by TLR ligands.
    Porrett PM; Yuan X; LaRosa DF; Walsh PT; Yang J; Gao W; Li P; Zhang J; Ansari JM; Hancock WW; Sayegh MH; Koulmanda M; Strom TB; Turka LA
    J Immunol; 2008 Aug; 181(3):1692-9. PubMed ID: 18641305
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Richardson JR; Armbruster NS; Günter M; Henes J; Autenrieth SE
    Front Immunol; 2018; 9():2603. PubMed ID: 30555457
    [No Abstract]   [Full Text] [Related]  

  • 9. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.
    Hanke ML; Kielian T
    Clin Sci (Lond); 2011 Nov; 121(9):367-87. PubMed ID: 21745188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship of dendritic cells, type 1 interferon system, regulatory T cells and toll-like receptors and their role in lichen planus and lupus erythematosus -- a literature review.
    Trucci VM; Salum FG; Figueiredo MA; Cherubini K
    Arch Oral Biol; 2013 Oct; 58(10):1532-40. PubMed ID: 23845753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovalbumin-Derived Peptides Activate Retinoic Acid Signalling Pathways and Induce Regulatory Responses Through Toll-Like Receptor Interactions.
    Martínez-Blanco M; Pérez-Rodríguez L; Lozano-Ojalvo D; Molina E; López-Fandiño R
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.
    Voo KS; Bover L; Harline ML; Weng J; Sugimoto N; Liu YJ
    J Immunol; 2014 Jul; 193(2):627-34. PubMed ID: 24928999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor signalling on Tregs: to suppress or not to suppress?
    van Maren WW; Jacobs JF; de Vries IJ; Nierkens S; Adema GJ
    Immunology; 2008 Aug; 124(4):445-52. PubMed ID: 18540962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets.
    Yang XF
    Front Biosci; 2008 Jan; 13():1472-99. PubMed ID: 17981643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.
    Ohkura N; Hamaguchi M; Sakaguchi S
    Trends Pharmacol Sci; 2011 Mar; 32(3):158-66. PubMed ID: 21237521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
    Liu G; Zhao Y
    Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in kidney disease and transplantation.
    Hu M; Wang YM; Wang Y; Zhang GY; Zheng G; Yi S; O'Connell PJ; Harris DC; Alexander SI
    Kidney Int; 2016 Sep; 90(3):502-14. PubMed ID: 27263492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.